Study identifies potential combination therapy for testing in deadly brain cancer

by Ludwig Cancer ResearchGraphical abstract. Credit:Cancer Cell(2022). DOI: 10.1016/j.ccell.2022.08.014A Ludwig Cancer Research study has identified a combination of three existing dr

Updated on: February 01,2024 19

Study identifies potential combination therapy for testing in deadly brain cancer

by Ludwig Cancer ResearchGraphical abstract. Credit:Cancer Cell(2022). DOI: 10.1016/j.ccell.2022.08.014A Ludwig Cancer Research study has identified a combination of three existing dr

Updated on:February 01,2024 19

How a patient with kidney cancer overcame several metastases against all expectations

by The Spanish National Cancer Research CentreGraphical abstract. Credit:International Journal of Cancer(2023). DOI: 10.1002/ijc.3457515 years ago, a woman in her thirties was diagnos

Updated on: February 01,2024 16

How a patient with kidney cancer overcame several metastases against all expectations

by The Spanish National Cancer Research CentreGraphical abstract. Credit:International Journal of Cancer(2023). DOI: 10.1002/ijc.3457515 years ago, a woman in her thirties was diagnos

Updated on:February 01,2024 16

New findings on therapy-related myeloid cancers

by Sylvester Comprehensive Cancer CenterCredit:Blood(2022). DOI: 10.1182/blood-2022-158992Scientists at Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Me

Updated on: February 01,2024 14

New findings on therapy-related myeloid cancers

by Sylvester Comprehensive Cancer CenterCredit:Blood(2022). DOI: 10.1182/blood-2022-158992Scientists at Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Me

Updated on:February 01,2024 14

Over half of English patients with NSCLC in areas with low socio-economic levels do not receive anti-cancer therapies

by International Association for the Study of Lung CancerCredit: Pixabay/CC0 Public DomainNovel anti-cancer therapies were not accessible to more than half of the patients in England who were diagnose

Updated on: February 01,2024 17

Over half of English patients with NSCLC in areas with low socio-economic levels do not receive anti-cancer therapies

by International Association for the Study of Lung CancerCredit: Pixabay/CC0 Public DomainNovel anti-cancer therapies were not accessible to more than half of the patients in England who were diagnose

Updated on:February 01,2024 17

First-line ribociclib and endocrine therapy may be more effective than combined chemotherapy in aggressive breast cancer

by American Association for Cancer ResearchCredit: Pixabay/CC0 Public DomainIn patients with hormone receptor-positive, HER2-negative, advanced breast cancer—including patients with visceral cris

Updated on: February 01,2024 15

First-line ribociclib and endocrine therapy may be more effective than combined chemotherapy in aggressive breast cancer

by American Association for Cancer ResearchCredit: Pixabay/CC0 Public DomainIn patients with hormone receptor-positive, HER2-negative, advanced breast cancer—including patients with visceral cris

Updated on:February 01,2024 15

An elusive mechanism of wasting syndrome cachexia revealed

by Justin Jackson , Medical XpressOSM induces Eda2r expression in muscle and the depletion of OSMR protects from muscle wasting. a, Mouse primary myotubes were treated with recombinant TNFα, IL-6, LIF

Updated on: February 01,2024 16

An elusive mechanism of wasting syndrome cachexia revealed

by Justin Jackson , Medical XpressOSM induces Eda2r expression in muscle and the depletion of OSMR protects from muscle wasting. a, Mouse primary myotubes were treated with recombinant TNFα, IL-6, LIF

Updated on:February 01,2024 16

Study: Tumor necroptosis promotes metastasis by modulating tumor-host immunity

by Impact Journals LLCTumor necroptosis promotes metastasis of breast cancer by suppressing anti-tumor immunity. Credit: 2023 Liu et al.A new editorial paper was published inOncotarget's&nbs

Updated on: February 01,2024 14

Study: Tumor necroptosis promotes metastasis by modulating tumor-host immunity

by Impact Journals LLCTumor necroptosis promotes metastasis of breast cancer by suppressing anti-tumor immunity. Credit: 2023 Liu et al.A new editorial paper was published inOncotarget's&nbs

Updated on:February 01,2024 14

A HER2-targeting peptide drug conjugate with better penetrability for effective breast cancer therapy

by Compuscript LtdSchematic diagram and pharmacokinetics of HER2-TP-cy5.5 and HER-TA-cy5.5 conjugate synthesis. (A) Schematic representation of the utilization of HER2-targeting peptide/antibody and C

Updated on: February 01,2024 10

A HER2-targeting peptide drug conjugate with better penetrability for effective breast cancer therapy

by Compuscript LtdSchematic diagram and pharmacokinetics of HER2-TP-cy5.5 and HER-TA-cy5.5 conjugate synthesis. (A) Schematic representation of the utilization of HER2-targeting peptide/antibody and C

Updated on:February 01,2024 10

Can an annual blood test find cancer while it's curable?

by Lisa M. KriegerCredit: Unsplash/CC0 Public DomainDespite decades of effort in the war against cancer, screening tests are available for only five types of the disease, representing less than one-th

Updated on: February 01,2024 11

Can an annual blood test find cancer while it's curable?

by Lisa M. KriegerCredit: Unsplash/CC0 Public DomainDespite decades of effort in the war against cancer, screening tests are available for only five types of the disease, representing less than one-th

Updated on:February 01,2024 11

Researchers discover how to steer army of immune cells toward cancer

by University of Rochester Medical CenterhHER2 CAR-T cell assays and in vivo distribution. a. Gating strategy for detection of hHER2-CAR-T cells. A median of > 90% of mouse CD8 T cells transdu

Updated on: February 01,2024 19

Researchers discover how to steer army of immune cells toward cancer

by University of Rochester Medical CenterhHER2 CAR-T cell assays and in vivo distribution. a. Gating strategy for detection of hHER2-CAR-T cells. A median of > 90% of mouse CD8 T cells transdu

Updated on:February 01,2024 19

Study identifies molecular basis of resistance to one of the main treatments for multiple myeloma

by The Spanish National Cancer Research CentreCredit: Pixabay/CC0 Public DomainMultiple myeloma is a type of cancer that affects plasma cells, the blood cells involved in the production of antibo

Updated on: February 01,2024 10

Study identifies molecular basis of resistance to one of the main treatments for multiple myeloma

by The Spanish National Cancer Research CentreCredit: Pixabay/CC0 Public DomainMultiple myeloma is a type of cancer that affects plasma cells, the blood cells involved in the production of antibo

Updated on:February 01,2024 10

Drug approved to help young patients battle a rare cancer

by Cara Murez HealthDay ReporterChildren and adults with a rare type of soft tissue cancer will now have a new treatment option that could have a big impact.The U.S. Food and Drug Administration has&n

Updated on: February 01,2024 19

Drug approved to help young patients battle a rare cancer

by Cara Murez HealthDay ReporterChildren and adults with a rare type of soft tissue cancer will now have a new treatment option that could have a big impact.The U.S. Food and Drug Administration has&n

Updated on:February 01,2024 19